Avidity Biosciences

RNA62

$46.71arrow_drop_down7.33%-$3.70

RNA62

$46.71

arrow_drop_down7.33%-$3.70

Performance History

Key Stats
Open	$49.96
Prev. Close	$50.45
EPS	-2.95
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	45.84	51.34
52 Week Range	4.82	49.41

Ratios







EPS	-2.95

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Avidity Biosciences (RNA)

Avidity Biosciences Inc (RNA) is a biotechnology company that specializes in the discovery, development, and commercialization of RNA-based therapeutics. With a focus on precision medicine, the company aims to revolutionize the treatment of serious diseases by harnessing the power of RNA. RNA-based therapeutics have the unique ability to target specific disease-causing genes and modulate their expression, offering a potentially safer and more effective alternative to traditional small molecule drugs. Avidity Biosciences is at the forefront of this emerging field, leveraging its proprietary AOC platform to design and develop novel RNA drugs.

The AOC platform combines the advantages of antibody-based therapeutics with nucleic acid technology, enabling the creation of highly specific and potent RNA drugs. By conjugating RNA payloads to antibody-like molecules, Avidity Biosciences is able to deliver the RNA directly to target cells, increasing the drug's efficacy and reducing off-target effects. This targeted approach holds great promise for the treatment of a wide range of diseases, including rare genetic disorders, neurodegenerative diseases, and certain types of cancer.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Ms. Sarah Boyce
Headquarters: San Diego
Employees: 186
Exchange: NASDAQ

Keep an eye on Avidity Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Avidity Biosciences 's (RNA) price per share?

The current price per share for Avidity Biosciences (RNA) is $46.71. The stock has seen a price change of -$3.7 recently, indicating a -7.33% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Avidity Biosciences (RNA)?

For Avidity Biosciences (RNA), the 52-week high is $49.41, which is 5.78% from the current price. The 52-week low is $4.82, the current price is 868.08% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Avidity Biosciences (RNA) a growth stock?

Avidity Biosciences (RNA) has shown an average price growth of -2.03% over the past three years. It has received a score of 97 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Avidity Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Avidity Biosciences (RNA) stock price performance year to date (YTD)?

As of the latest data, Avidity Biosciences (RNA) has a year-to-date price change of 409.93%. Over the past month, the stock has experienced a price change of 7.38%. Over the last three months, the change has been 0.89%. Over the past six months, the figure is 93.34%.

help

Is Avidity Biosciences (RNA) a profitable company?

Avidity Biosciences (RNA) has a net income of -$212.22M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 78.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -4.04K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $9.56M, with a revenue growth rate of 3.64%, providing insight into the company's sales performance and growth. The gross profit is $7.46M. Operating income is noted at -$235.6M. Furthermore, the EBITDA is -$282.67M.

help

What is the market capitalization of Avidity Biosciences (RNA)?

Avidity Biosciences (RNA) has a market capitalization of $5.96B. The average daily trading volume is 46.92, indicating the stock's liquidity and investor engagement.